HIV-1 Infected Adults with Controlled Viremia

Clinical trial pipeline · Data from ClinicalTrials.gov

See which HIV-1 Infected Adults with Controlled Viremia trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 4

NCT06646562

Long Acting Cabotegravir Plus Rilpivirine in People Living with HIV-1 Aged ≥ 60 Years for 24 Months.

People Living with HIV-1 (PLHIV) are an important group of patients attending their specialist's and continue growing thanks to efficacy antiretroviral treatmen…

Spain120 participantsStarted 2025-03-03

Treatment: Cabotegravir LA + Rilpivirine LA

All recent trials (2 shown)

Active — Not RecruitingPhase 1

NCT03374202

Safety and Tolerability of AAV8 Delivery of a Broadly Neutralizing Antibody in Adults Living With HIV: a Phase 1, Dose-e…

Background: The Human Immunodeficiency Virus (HIV) attacks the immune system. Scientists have created a gene that could be transferred to the cells of people w…

United States10 participantsStarted 2018-01-11

Treatment: VRC-HIVAAV070-00-GT (AAV8-VRC07)